Cargando…
Increased Expression of Oct4, Nanog and CD24 Predicts Poor Response to Chemo-Radiotherapy and Unfavourable Prognosis in Locally Advanced Oral Squamous Cell Carcinoma
BACKGROUND: Current study investigates the role of Oct4, Nanog and CD24 in locally-advanced oral squamous cell carcinoma (OSCC), to evaluate whether the expression of these markers can predict efficacy of neoadjuvant-chemo-radiotherapy and survival of patients. METHODS: Biomarker expression was eval...
Autores principales: | Mishra, Sridhar, Tiwari, Vandana, Arora, Aditi, Gupta, Seema, Anand, Nidhi, Husain, Nuzhat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779456/ https://www.ncbi.nlm.nih.gov/pubmed/32986350 http://dx.doi.org/10.31557/APJCP.2020.21.9.2539 |
Ejemplares similares
-
CD24 and Nanog expression in Stem Cells in Glioblastoma: Correlation with Response to Chemoradiation and Overall Survival
por: Soni, Priyanka, et al.
Publicado: (2017) -
Nanog, Oct4 and Tet1 interplay in establishing pluripotency
por: Olariu, Victor, et al.
Publicado: (2016) -
High expression of Oct4 and Nanog predict poor prognosis in intrahepatic cholangiocarcinoma patients after curative resection
por: Zhang, Mei-xia, et al.
Publicado: (2019) -
Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas
por: Rasti, Arezoo, et al.
Publicado: (2018) -
Monocyte HLADR and Immune Dysregulation Index as Biomarkers for COVID-19 Severity and Mortality
por: Awasthi, Namrata Punit, et al.
Publicado: (2022)